Inhaled chemicals may enhance allergic airway inflammation in ovalbumin-sensitised mice

Toxicology

Volumn 226, Issue 2-3, 2006, Pages 161-171

  Ban, Masarin ^a   Langonné, Isabelle ^a   Huguet, Nelly ^a   Pépin, Elsa ^a   Morel, Georges ^a  

^a INSTITUT NATIONAL DE RECHERCHE ET DE SÉCURITÉ   (France)

Author keywords

Adjuvant effect; Inhaled chemicals; Mouse asthma model

Indexed keywords

ALLERGEN; ALUMINUM POTASSIUM SULFATE; CHLOROFORM; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; STYRENE; VINYLIDENE CHLORIDE;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INHALATION; LUNG LYMPH FLOW; LYMPH NODE CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SENSITIZATION; TH2 CELL;

ALUM COMPOUNDS; ANIMALS; ASTHMA; CHLOROFORM; CYTOKINES; DICHLOROETHYLENES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN E; INFLAMMATION; INHALATION EXPOSURE; INTERLEUKINS; LUNG; LYMPH NODES; MICE; MICE, INBRED BALB C; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; SOLVENTS; STYRENE; TH2 CELLS;

EID: 33747841609     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.06.012     Document Type: Article

References (31)

1. Alam R., Stafford S., Forsythe P., and Grant J.A. RANTES is a chemotactic and activating factor for eosinophils. J. Immunol. 150 (1993) 3442-3447
2. Arif A.A., Whitehead L.W., Delclos G.L., Tortolero S.R., and Lee E.S. Prevalence and risk factors of work related asthma by industry among United States workers: data from the third national health and nutrition examination survey. Occup. Environ. Med. 59 (1988-94) 505-511
3. Ban M., Hettich D., and Bonnet P. Effect of inhaled industrial chemicals on systemic and local immune response. Toxicology 184 (2003) 41-50
4. Ban M., Hettich D., Goutet M., and Bonnet P. TDI inhalation in guinea-pigs involves migration of dendritic cells. Toxicol. Lett. 93 (1997) 185-194
5. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
6. Beasley R., Crane J., Lai C.K., and Pearce N. Prevalence and aetiology of asthma. J. Allergy Clin. Immunol. 105 (2000) 466-472
7. Coffman R.L., Lebman D.A., and Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54 (1993) 229-270
8. Carter J.D., Ghio A.J., Samet J.M., and Devlin R.B. Cytokine production by human airway epithelial cells after exposure to an air pollution particle is metal-dependent. Toxicol. Appl. Pharmacol. 146 (1997) 180-188
9. De Haar C., Hassing I., Bol M., Bleumink R., and Pieters R. Ultrafine carbon black particles cause early airway inflammation and have adjuvant activity in a mouse allergic airway disease model. Toxicol. Sci. 87 (2005) 409-418
10. Finkelman F.D., Yang M., Orekhova T., Clyne E., Bernstein J., Whitekus M., and Diaz-Sanchez D. Diesel exhaust particles inhibit Interferon-γ production by inhibiting cytokine effects on NK and NKT cells. J. Immunol. 172 (2004) 3808-3838
11. Foster P.S., Hogan S.P., Matthaei K.I., and Young I.G. Interleukin-4 and interleukin-5 as targets for the inhibition of eosinophilic inflammation and allergic airways hyperreactivity. Mem. Inst. Oswaldo Cruz 92 (1997) 55-61
12. Foster P.S., Hogan S.P., Yang M., Mattes J., Young I.G., Matthaei K.I., Kumar R.K., Mahalingam S., and Webb D.C. Interleukin-5 and eosinophils as therapeutic targets for asthma. Trends Mol. Med. 8 (2002) 162-167
13. Funabashi H., Shima M., Kuwaki T., Hiroshima K., and Kuriyama T. Effects of repeated ozone exposure on pulmonary function and bronchial responsiveness in mice sensitised with ovalbumin. Toxicology 204 (2004) 75-83
14. Gavett S.H., O'Hearn D.J., Li X., Huang S.K., Finkelman F.D., and Wills-Karp M. IL-12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th-2 cytokine expression in mice. J. Exp. Med. 182 (1995) 1527-1536
15. Holgate S.T. The epidemic of allergy and asthma. Nature 402 (1999) B2-B4
16. Howardth P.H. Is allergy increasing? Early life influences. Clin. Exp. Allergy 28 Suppl. (1998) 2-7
17. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3 (2003) 984-993
18. Kay A.B. Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344 (2001) 30-37
19. Kuperman D.A., Huang X., Koth L.L., Chang G.H., Dolganov G.M., Zhu Z., Elias J.A., Sheppard D., and Erle D.J. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactiviy and mucus overproduction in asthma. Nat. Med. 8 (2002) 885-889
20. Lambrecht B.N., Salomon B., Klatzmann D., and Pauwels R.A. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitised mice. J. Immunol. 160 (1998) 4090-4097
21. Lack G., Bradley K.L., Hamelmann E., Renz H., Loader J., Leung D.Y., Larsen G., and Gelfand E.W. Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J. Immunol. 157 (1996) 1432-1439
22. Lambrecht B.N., De Veerman M., Coyle A.J., Gutierrez-Ramos J., Thielemans K., and Pauwels R.A. Dendritic cells induce Th2 responses to inhaled antigen leading to eosinophilic airway inflammation. J. Clin. Invest. 106 (2000) 551-559
23. Laskin D.L., Weinberger B., and Laskin J.D. Functional heterogeneity in liver and lung macrophages. J. Leukocyte Biol. 70 (2001) 163-170
24. Moss R.B., Moll T., El-Kalay M., Kohne C., Soo Hoo W., Encinas J., and Carlo D.J. Th1/Th-2 cells in inflammatory disease states: therapeutic implications. Expert Opin. Biol. Ther. 4 (2004) 1887-1896
25. Nakamura T., Lee R.K., Nam S.Y., Podack E.R., Bottomly K., and Flavell R.A. Roles of IL-4 and IFN-γ in stabilizing the T helper cell type 1 and 2 phenotype. J. Immunol. 158 (1997) 2648-2653
26. Palframan R.T., Collins P.D., Williams T.J., and Rankin S.M. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 91 (1998) 2240-2248
27. Peters-Golden M. The alveolar macrophage: the forgotten cell in asthma. Am. J. Respir. Cell. Mol. Biol. 31 (2004) 3-7
28. Reisinger J., Triendl A., Kuchler E., Bohle B., Krauth M.T., Rauter I., Valent P., Koenig F., Valenta R., and Niederberger V. IFN-γ-enhanced allergen penetration across respiratory epithelium augments allergic inflammation. J. Allergy Clin. Immunol. 115 (2005) 973-981
29. Steerenberg P.A., Withagen C.E., van Dalen W.J., Dormans J.A.M.A., Cassee F.R., Heisterkamp S.H., and van Loveren H. Adjuvant activity of ambient particulate matter of different sites, sizes and seasons in a respiratory allergy mouse model. Toxicol. Appl. Pharmacol. 200 (2004) 186-200
30. Tang C., Inman M.D., van Rooijen N., Yang P., Shen H., Matsumoto K., and O'Byrne P.M. Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-γ-dependent mechanism. J. Immunol. 166 (2001) 1471-1478
31. Yamauchi T., Shima M., Kuwaki T., Ando M., Ohmichi M., Fukuda Y., and Adachi M. Acute effects of ozone exposure on lung function in mice sensitised to ovalbumin. Toxicology 172 (2002) 69-78